← FDA Drug Approvals (Drugs@FDA)

TAGRISSO

NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2015-11-13

Drug application

FDA Application #

NDA208065

Application type

New Drug Application

Brand name

TAGRISSO

Generic name

OSIMERTINIB

Active ingredients

OSIMERTINIB MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ASTRAZENECA

Manufacturer

AstraZeneca Pharmaceuticals LP

First approval

2015-11-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown